Hosts: Charlie Huntington of Bio Strategy Partners & Kimon Hatza, Esq. of MillCrest Law, LLP
Guests: Edward Seguine, CEO of Clinical Ink

Show Notes

• What is Clinical Ink?
• Where do you find good Bio Tech experts?
• How has the Affordable Care Act changed the way that clinical trials are conducted?
• How have you shorten the most important element of a trial from 3 weeks to 35 minutes?
• Is this “disruptive Technology”?
• Who is Tommy Littlejohn?
• How will electronic records change medical programs?
• How will you measure success with Clinical Ink?

Podcast: Play in new window | Download